Cargando…

Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?

Harm reduction is a controversial model for treating drug users, with little formal research available on its operation and effectiveness. In order to advance the field, we first conducted participatory research of harm reduction with 120 clients using nominal-group technique to develop culturally r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Susan J, Ruefli, Terry
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420490/
https://www.ncbi.nlm.nih.gov/pubmed/15171790
http://dx.doi.org/10.1186/1477-7517-1-7
_version_ 1782121483875647488
author Rogers, Susan J
Ruefli, Terry
author_facet Rogers, Susan J
Ruefli, Terry
author_sort Rogers, Susan J
collection PubMed
description Harm reduction is a controversial model for treating drug users, with little formal research available on its operation and effectiveness. In order to advance the field, we first conducted participatory research of harm reduction with 120 clients using nominal-group technique to develop culturally relevant outcomes to measure progress. Second, we conducted focus group interviews with a different group of clients to help validate the outcomes. Third, we used the outcomes in an evaluation of the largest harm reduction program in New York City, which involved a representative sample of 261 and entailed baseline, post, and six follow-up assessments. The participatory research resulted in outcomes of 10 life areas important to drug users. Evaluation results showed that program participants made positive improvements across most outcomes, with the most substantial progress made in how clients dealt with drug-use problems. Along with their participation in the program, progress in some outcomes was also associated with clients' type of drug use (i.e., stable vs. chaotic), where more stable drug use was associated with better ways of making an income and types of housing. Surprisingly, progress was not associated with the kinds or numbers of services received or the length of time in the program. This was attributed to the service delivery model of harm reduction, in which clients are less inclined to associate their success with a single staff person or with a single service or intervention received than with the program as a whole.
format Text
id pubmed-420490
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-4204902004-06-11 Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users? Rogers, Susan J Ruefli, Terry Harm Reduct J Research Harm reduction is a controversial model for treating drug users, with little formal research available on its operation and effectiveness. In order to advance the field, we first conducted participatory research of harm reduction with 120 clients using nominal-group technique to develop culturally relevant outcomes to measure progress. Second, we conducted focus group interviews with a different group of clients to help validate the outcomes. Third, we used the outcomes in an evaluation of the largest harm reduction program in New York City, which involved a representative sample of 261 and entailed baseline, post, and six follow-up assessments. The participatory research resulted in outcomes of 10 life areas important to drug users. Evaluation results showed that program participants made positive improvements across most outcomes, with the most substantial progress made in how clients dealt with drug-use problems. Along with their participation in the program, progress in some outcomes was also associated with clients' type of drug use (i.e., stable vs. chaotic), where more stable drug use was associated with better ways of making an income and types of housing. Surprisingly, progress was not associated with the kinds or numbers of services received or the length of time in the program. This was attributed to the service delivery model of harm reduction, in which clients are less inclined to associate their success with a single staff person or with a single service or intervention received than with the program as a whole. BioMed Central 2004-06-01 /pmc/articles/PMC420490/ /pubmed/15171790 http://dx.doi.org/10.1186/1477-7517-1-7 Text en Copyright © 2004 Rogers and Ruefli; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Rogers, Susan J
Ruefli, Terry
Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?
title Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?
title_full Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?
title_fullStr Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?
title_full_unstemmed Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?
title_short Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?
title_sort does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420490/
https://www.ncbi.nlm.nih.gov/pubmed/15171790
http://dx.doi.org/10.1186/1477-7517-1-7
work_keys_str_mv AT rogerssusanj doesharmreductionprogrammingmakeadifferenceinthelivesofhighlymarginalizedatriskdrugusers
AT ruefliterry doesharmreductionprogrammingmakeadifferenceinthelivesofhighlymarginalizedatriskdrugusers